Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
42.59
-1.51 (-3.42%)
May 15, 2026, 4:00 PM EDT - Market closed
Travere Therapeutics Employees
Travere Therapeutics had 497 employees as of December 31, 2025. The number of employees increased by 112 or 29.09% compared to the previous year.
Employees
497
Change (1Y)
112
Growth (1Y)
29.09%
Revenue / Employee
$1,078,863
Profits / Employee
-$43,103
Market Cap
3.96B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 497 | 112 | 29.09% |
| Dec 31, 2024 | 385 | 5 | 1.32% |
| Dec 31, 2023 | 380 | -82 | -17.75% |
| Dec 31, 2022 | 462 | 152 | 49.03% |
| Dec 31, 2021 | 310 | 48 | 18.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Crinetics Pharmaceuticals | 594 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 154 |
| NewAmsterdam Pharma Company | 100 |
| Oruka Therapeutics | 68 |
TVTX News
- 3 days ago - Travere Therapeutics Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 4 days ago - Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 9 days ago - Travere Therapeutics to Participate at Upcoming Investor Conferences - Business Wire
- 10 days ago - Travere Prices Upsized $475.0 Million Convertible Senior Notes Offering to Refinance 2029 Convertible Notes - Business Wire
- 11 days ago - Travere Therapeutics announces $400M convertible senior notes offering - TheFly
- 11 days ago - Travere Announces Proposed Convertible Senior Notes Offering to Refinance 2029 Convertible Notes - Business Wire
- 11 days ago - Travere Therapeutics price target raised to $60 from $45 at TD Cowen - TheFly
- 11 days ago - Travere Therapeutics price target raised to $55 from $53 at Wedbush - TheFly